Palo Alto Investors LP Exact Sciences Corp Transaction History

Palo Alto Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $28.5 Million - $38.6 Million	-314,889 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $87,926 - $129,693	1,569 Added 0.5%	314,889 $19.9 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $22,741 - $42,045	601 Added 0.19%	313,320 $18.7 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $73,388 - $106,027	1,843 Added 0.59%	312,719 $12.6 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $5.68 Million - $7.39 Million	-122,200 Reduced 28.22%	310,876 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $16 Million - $20.4 Million	433,076	433,076 $20.4 Million

636

166M

1.93M

1.23M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

Stay updated on Palo Alto Investors LP with notifications on news.